WO2009063931A1 - 血行促進作用の評価方法、血行促進物質のスクリーニング方法、および血行促進剤 - Google Patents

血行促進作用の評価方法、血行促進物質のスクリーニング方法、および血行促進剤 Download PDF

Info

Publication number
WO2009063931A1
WO2009063931A1 PCT/JP2008/070657 JP2008070657W WO2009063931A1 WO 2009063931 A1 WO2009063931 A1 WO 2009063931A1 JP 2008070657 W JP2008070657 W JP 2008070657W WO 2009063931 A1 WO2009063931 A1 WO 2009063931A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood circulation
substance
promoting
activity
promoting activity
Prior art date
Application number
PCT/JP2008/070657
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
Katsuya Nagai
Mamoru Tanida
Jiao Shen
Yuko Horii
Original Assignee
Anbas Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anbas Corporation filed Critical Anbas Corporation
Publication of WO2009063931A1 publication Critical patent/WO2009063931A1/ja

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Physiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
PCT/JP2008/070657 2007-11-15 2008-11-13 血行促進作用の評価方法、血行促進物質のスクリーニング方法、および血行促進剤 WO2009063931A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-297340 2007-11-15
JP2007297340 2007-11-15

Publications (1)

Publication Number Publication Date
WO2009063931A1 true WO2009063931A1 (ja) 2009-05-22

Family

ID=40638778

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/070657 WO2009063931A1 (ja) 2007-11-15 2008-11-13 血行促進作用の評価方法、血行促進物質のスクリーニング方法、および血行促進剤

Country Status (2)

Country Link
JP (1) JP5504388B2 (enrdf_load_stackoverflow)
WO (1) WO2009063931A1 (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013018719A (ja) * 2011-07-08 2013-01-31 Kao Corp 皮膚血行促進化粧料
US20130149399A1 (en) * 2010-05-31 2013-06-13 Shiseido Company ,Ltd. Skin temperature elevating agent, and cosmetic composition, food and sundry article containing the same

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6017330B2 (ja) * 2013-01-30 2016-10-26 花王株式会社 過活動膀胱の予防又は改善剤
JP2015196031A (ja) * 2014-04-03 2015-11-09 有限会社日本健康科学研究センター 冷え性、及び、むくみ改善の為の足浴用袋製剤。
KR102561733B1 (ko) * 2023-04-03 2023-07-31 한국 한의학 연구원 고추 부산물 추출물을 유효성분으로 함유하는 혈행 개선용 조성물

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10310528A (ja) * 1997-03-12 1998-11-24 Hayashibara Takeshi 血行改善剤
JP2000044467A (ja) * 1998-07-31 2000-02-15 Lion Corp 血流促進剤
JP2001213717A (ja) * 2000-01-28 2001-08-07 Kao Corp 血行促進剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06234628A (ja) * 1993-02-09 1994-08-23 Kao Corp 皮膚外用剤
JP2003095985A (ja) * 2001-09-26 2003-04-03 Lion Corp 血行促進組成物
JP2005206596A (ja) * 2003-12-26 2005-08-04 Osaka Industrial Promotion Organization 芳香療法用組成物

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10310528A (ja) * 1997-03-12 1998-11-24 Hayashibara Takeshi 血行改善剤
JP2000044467A (ja) * 1998-07-31 2000-02-15 Lion Corp 血流促進剤
JP2001213717A (ja) * 2000-01-28 2001-08-07 Kao Corp 血行促進剤

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130149399A1 (en) * 2010-05-31 2013-06-13 Shiseido Company ,Ltd. Skin temperature elevating agent, and cosmetic composition, food and sundry article containing the same
JP2013018719A (ja) * 2011-07-08 2013-01-31 Kao Corp 皮膚血行促進化粧料

Also Published As

Publication number Publication date
JP5504388B2 (ja) 2014-05-28
JP2009139371A (ja) 2009-06-25

Similar Documents

Publication Publication Date Title
WO2009063931A1 (ja) 血行促進作用の評価方法、血行促進物質のスクリーニング方法、および血行促進剤
MX2010014228A (es) Metodos y productos de diagnostico del p/gf-1 acompañante.
AU2018260825A1 (en) Compositions and Methods for Lowering Levels of High-Sensitivity (hs-CRP) in a Subject
Allen et al. Dietary quality and encephalization in platyrrhine primates
WO2011122923A3 (en) Long-acting interferon beta formulation using immunoglobulin fragment
WO2011156734A3 (en) Method of characterizing vascular diseases
WO2008143145A1 (ja) 皮膚保湿作用の評価方法、およびこれを用いた保湿物質のスクリーニング方法
MA38972B1 (fr) Procédés et outils relatifs à l'administration d'un milieu de contraste
ATE403398T1 (de) Sequentielle computertomographie methode
WO2009063807A1 (ja) 発毛促進作用の評価方法、発毛促進物質のスクリーニング方法、および発毛促進剤
WO2008065408A3 (en) Modulation of prostaglandin/cyclooxygenase metabolic pathways
JP2009139371A5 (enrdf_load_stackoverflow)
JP2011251952A5 (enrdf_load_stackoverflow)
CN102778525A (zh) 一种动物源食品中水杨苯胺类兽药残留量的检测方法
EP1663130A4 (en) EXTRACT OF SEMEN NELUMBINIS TO TREAT THE LOW
McIntosh et al. Desbutylhalofantrine: evaluation of QT prolongation and other cardiovascular effects after intravenous administration in vivo
Moody et al. Improving the quality of ECGs collected using mobile phones: The PhysioNet/Computing in Cardiology Challenge 2011
Li et al. Hematologic and Biochemical Reference of\nCaptive Giant Pandas Based on Non-stress Sampling Methods
Kim et al. Spatial and Temporal Responses of Arterial and Venous Blood Volume Changes
Cho et al. A research study of school children's preferences for insanitary food near school
Sakata et al. Demonstration of patho-physiological roles of PGE2 receptor EP4 subtype using a novel EP4 subtype selective agonist, ONO-AEI-329
Wang et al. Age Effect on SAR Evaluation of Dielectric Tissue Properties for Mobile Telephones
Franks Role of endocannabinoid system confirmed in patients with cirrhosis
Omoyakhi et al. Chemical adjustments during aestivation by the giant African land snails, Archachatina marginata and Achatina achatina
Boudon et al. EVALUATION OF SPARFLOXACIN PHOTOTOXICITY USING MASS SPECTROMETRY IMAGING

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08849563

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08849563

Country of ref document: EP

Kind code of ref document: A1